球囊导引导管对STRATIS取栓登记研究临床与血管造影结局的影响
STRATIS为前瞻性多中心登记研究,纳入接受Solitaire支架取栓的大血管闭塞患者,由核心实验室盲法评估血管造影。球囊导引导管(BGC)组首过效应(FPE)率、改良FPE率及3个月功能独立率均高于远端通路导管和常规导引导管组;BGC使用是FPE、改良FPE和功能独立的独立预测因素。
要点
- BGC组首过效应成功率为48%,高于常规导引导管26%和远端通路导管35%。
- BGC组改良首过效应成功率为66%,高于常规导引导管42%和远端通路导管55%。
- BGC组3个月功能独立率为61%,高于常规导引导管42%和远端通路导管52%。
核心结论
- BGC使用是首过效应(FPE)、改良FPE和功能独立的独立预测因素,提示其常规使用可能提高早期血管再通成功率和良好临床结局。
研究设计与样本
- STRATIS为前瞻性多中心研究,纳入以Solitaire支架取栓作为一线治疗的大血管闭塞患者。
- 独立核心实验室在不知临床结局的情况下回顾所有手术和血管造影数据,分类手术技术、目标血栓位置、每次取栓后再通及支架取栓次数。
主要发现
- BGC组首次取栓后FPE率为48%(212/443),常规导引导管组为26%(16/62),P=0.001;远端通路导管组为35%(83/235),P=0.002。
- BGC组改良FPE率为66%(294/443),常规导引导管组为42%(26/62),P<0.001;远端通路导管组为55%(129/234),P=0.003。
- BGC组功能独立率为61%(253/415),常规导引导管组为42%(23/55),P=0.007;远端通路导管组为52%(113/218),P=0.027。
- 最终血管再通率和死亡率在各组间无差异。
关键数值与推荐
- 主要临床终点为3个月功能独立(改良Rankin量表0-2分),由现场判定。
- 血管造影终点为首过效应(FPE)成功率,定义为单次器械尝试后改良脑梗死溶栓分级≥2c,由核心实验室判定。
- 同时评估改良FPE,定义为改良脑梗死溶栓分级≥2b。
临床怎么用
- 在急性缺血性卒中大血管闭塞取栓中,可考虑使用BGC作为辅助技术以提高首过效应和功能独立率。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Mechanical thrombectomy has been shown to improve clinical outcomes in patients with acute ischemic stroke. However, the impact of balloon guide catheter (BGC) use is not well established. Methods- STRATIS (Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke) was a prospective, multicenter study of patients with large vessel occlusion treated with the Solitaire stent retriever as first-line therapy. In this study, an independent core laboratory, blinded to the clinical outcomes, reviewed all procedures and angiographic data to classify procedural technique, target clot location, recanalization after each pass, and determine the number of stent retriever passes. The primary clinical end point was functional independence (modified Rankin Scale, 0-2) at 3 months as determined on-site, and the angiographic end point was first-pass effect (FPE) success rate from a single device attempt (modified Thrombolysis in Cerebral Infarction, ≥2c) as determined by a core laboratory. Achieving modified FPE (modified Thrombolysis in Cerebral Infarction, ≥2b) was also assessed. Comparisons of clinical outcomes were made between groups and adjusted for baseline and procedural characteristics. All participating centers received institutional review board approval from their respective institutions. Results- Adjunctive technique groups included BGC (n=445), distal access catheter (n=238), and conventional guide catheter (n=62). The BGC group had a higher rate of FPE following first pass (212/443 [48%]) versus conventional guide catheter (16/62 [26%]; P=0.001) and distal access catheter (83/235 [35%]; P=0.002). Similarly, the BGC group had a higher rate of modified FPE (294/443 [66%]) versus conventional guide catheter (26/62 [42%]; P<0.001) and distal access catheter (129/234 [55%]; P=0.003). The BGC group achieved the highest rate of functional independence (253/415 [61%]) versus conventional guide catheter (23/55 [42%]; P=0.007) and distal access catheter (113/218 [52%]; P=0.027). Final revascularization and mortality rates did not differ across the groups. Conclusions- BGC use was an independent predictor of FPE, modified FPE, and functional independence, suggesting that its routine use may improve the rates of early revascularization success and good clinical outcomes. Clinical Trial Registration- URL: https://www.clinicaltrials.gov . Unique identifier: NCT02239640.
引用
- Zaidat OO, Mueller-Kronast NH, Hassan AE, et al. Impact of Balloon Guide Catheter Use on Clinical and Angiographic Outcomes in the STRATIS Stroke Thrombectomy Registry. Stroke. 2019. PMID: 30776994. doi:10.1161/STROKEAHA.118.021126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。